Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-715-1 | CAS number: 13466-20-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Description of key information
No data regarding reproductive toxicity is available for barium bis(dihydrogen orthophosphate). Reliable data is available for structural similar substance barium chloride dihydrate (CAS 10326-27-9).
NOAEL (fertility), rat, oral = 200 (male) and 180 (female) mg barium/kg bw/day
NOAEL (fertility), mice, oral = 205 (male) and 200 (female) mg barium/kg bw/day
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- weight of evidence
- Justification for type of information:
- Please refer to the analogue justification attached to chapter 13
- Reason / purpose for cross-reference:
- read-across source
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- rat
- Effect level:
- >= 4 000 ppm (nominal)
- Based on:
- test mat.
- Remarks:
- equivalent to 200 or 180 mg barium/kg bw/day for males or females, respectivley
- Sex:
- male/female
- Basis for effect level:
- other: no effects observed up to the highest dose tested
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- mice
- Effect level:
- >= 2 000 ppm (nominal)
- Based on:
- test mat.
- Remarks:
- equivalent to 205 or 200 mg barium/kg bw/day for males or females, respectivley
- Sex:
- male/female
- Basis for effect level:
- other: no adverse effects observed up to the highest dose tested
- Key result
- Critical effects observed:
- no
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- rat
- Generation:
- F1
- Effect level:
- >= 4 000 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no effects observed up to the highest dose tested
- Key result
- Dose descriptor:
- NOAEL
- Remarks:
- mice
- Generation:
- F1
- Effect level:
- >= 2 000 ppm (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no effects observed up to the highest dose tested
- Key result
- Critical effects observed:
- no
- Key result
- Reproductive effects observed:
- no
- Conclusions:
- Taken together all data of these studies, there are no indications of a substantial impairment of fertility in rats up to the highest dose tested. Thus, the NOAEL was 4000 ppm (to average doses of 200 and 180 mg barium/kg bw/d to male and and female rats, respectively). NOAELs on developmental toxicity for rats of 4000 ppm were derived from this study. However, this NOAEL is of limited value to evaluate the potential for barium to induce developmental effects because there was no exposure of the females during gestation.
Regarding mice, there are also no indications of a substantial impairment of fertility in mice up to the highest dose tested. Thus, the NOAEL was 2000 ppm (to average doses of 205 and 200 mg barium/kg bw/d to male and and female mice, respectively). NOAELs on developmental toxicity for mice of 2000 ppm were derived from this study. However, this NOAEL is of limited value to evaluate the potential for barium to induce developmental effects because there was no exposure of the females during gestation.
Thus, as explained in the analogue justification barium bis(hydrogen orthophosphate) is also considered to have no potential for developmental toxicity.
Reference
Study in mice: Drinking water containing 500, 1000, or 2000 ppm barium chloride dihydrate was estimated to deliver daily doses of 55, 100, or 205 mg barium/kg bw to male and 60, 110, or 200 mg barium/kg bw to female mice.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 180 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises adequate, reliable (Klimisch score 2) and consistent studies, from a reference substance with similar structure and intrinsic properties. Read-across is justified based on similarities in PC/ECO/TOX properties (refer to endpoint discussion for further details).
The selected studies are thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Effect on fertility: via inhalation route
- Endpoint conclusion:
- no study available
Effect on fertility: via dermal route
- Endpoint conclusion:
- no study available
Additional information
No data regarding reproductive toxicity is available for barium bis(dihydrogen orthophosphate). Reliable data is available for barium chloride dihydrate (CAS 10326-27-9). Since the main toxicity of barium bis(dihydrogen orthophosphate) can be attributed to barium, barium chloride dihydrate can be used as read across. For more detail on the read across justification please refer to the analogue justification provided in section 13.
The data base consists of single-generation reproductive toxicity studies in rats and mice (Dietz et al., 1992) which is similar to OECD guideline 421. In this study, groups of male and female F-344/N rats and B6C3F1 mice (20/sex/species/group) were exposed to barium chloride dihydrate in the drinking water for 60 days (males) or 30 days (females). The barium chloride dihydrate concentrations were 0, 1000, 2000, or 4000 ppm for the rats and 0, 500, 1000, or 2000 ppm for the mice. Estimated doses were not reported for this study. The dosages from a subchronic study conducted by the same authors (NTP, 1994; Dietz et al., 1992) were therefore used to represent approximate dosages for this study. For the rats, estimated barium doses were 0, 65, 110, and 200 mg/kg-day for males and 0, 65, 115, and 180 mg/kg-day for females. For mice the estimates were 0, 55, 100, and 205 mg/kg-day for males and 0, 60, 110, and 200 mg/kg-day for females. After the exposure period, males and females from the same exposure groups were housed together until there was evidence of mating or until the end of the mating period (8 days). The following endpoints were used to assess potential reproductive toxicity: length of pregnancy, number of implantation sites, number of live and dead offspring, pup weights at birth and on the fifth day after parturition, external abnormalities of pups, gross examination of the vagina, cervix, oviduct, and uterus of the F0 dams, and evaluation of sperm density, morphology, and motility, and reproductive organ weights of the F0 males.
Pregnancy rates in the rat study were below historically normal values for the laboratory, ranging from 40% in the controls to 65% in the high dose group, but barium treatment did not appear to be the reason. The problem of low fecundity was not investigated by remating because of schedule restrictions. No significant alterations in gestation length, pup survival, or occurrence of external abnormalities were observed. A marginal but statistically not significant reduction in live litter sizes was observed in the 4000 ppm treatment group compared to controls at birth and day 5 (day 0, 9.0 ± 1.37 pups in controls compared to 7.2 ± 0.52 pups in the 4000 ppm treatment group; day 5, 9.3 ± 1.16 pups in controls compared to 7.1 ± 0.56 in 4000 ppm treatment group; mean ± SEM). The number of implants per pregnant dam were also marginally reduced from 9.6 ± 1.10 in controls to 7.7 ± 5.2 in pups in the 4000 ppm treatment group, but the effect was not statistically significant. A statistically significant (p < 0.01) decrease in live pup weight at birth was observed in the 4000 ppm group (5.2 g vs. 5.7 g in controls); however, no significant alterations in pup body weight were observed at 5 days of age.
Pregnancy rates in mice ranged from 55% in controls to 55% - 70% in the barium-exposed groups. No alterations in maternal weight gain, average length of gestation, pup survival, or pup weights were observed in mice. A statistically significant (p < 0.05) decrease in average litter size occurred on days 0 and 5 in the 1000 ppm treatment group but not in the 2000 ppm treatment group (day 0, 10.7 ± 0.40 pups in controls compared to 7.9 ± 1.02 pups for 1000 ppm treatment group; day 5, 10.8 ± 0.38 pups compared to 7.7 ± 0.97 pups in the 1000 ppm treatment group). No external abnormalities were observed in the mouse offsprings.
No alterations in epididymal sperm counts, sperm motility, sperm morphology, testicular or epididymal weights, or vaginal cytology were observed in rats or mice.
Based on the limited amount of data available, it is not possible to make a definitive conclusion about the potential for barium to impair reproductive functions but it does not indicate that barium impairs fertility so no further study regarding reproductive toxicity is justified for that tonnage band.
Effects on developmental toxicity
Description of key information
No data regarding developmental toxicity is available for barium bis(dihydrogen orthophosphate). Reliable data is available for the strucatural similar substance barium chloride dihydrate (CAS 10326-27-9).
OECD 414 (oral, rat):
NOAEL (materanl toxicity) = 30 mg /kg bw/day corresponding to 17 mg Ba/kg bw/day
NOAEL (developmental toxicity) >= 100 mg/kg bw/day corresponding to 56 mg Ba/kg bw/day
Link to relevant study records
- Endpoint:
- developmental toxicity
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- Please refer to the analogue justification attached to chapter 13
- Reason / purpose for cross-reference:
- read-across source
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 30 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Basis for effect level:
- mortality
- Abnormalities:
- no effects observed
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 100 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: no effects up to the highest dose tested
- Key result
- Abnormalities:
- no effects observed
- Key result
- Developmental effects observed:
- no
- Conclusions:
- Daily administration of the source substance barium chloride dihydrate at dose levels of 0, 10, 30 or 100 mg/kg bw/day to pregnant rats from gestation day 1 up to and including gestation day 20, resulted in maternal toxicity as evidenced by the spontaneous deaths of two animals on gestation day 21 and the conditional decline of another animal on gestation day 21 in the high dose group. No developmental toxicity was observed. The NOAEL for maternal toxicity was therefore 30 mg/kg bw/day. In absence of developmental effects the NOAEL for prenatal developmental toxicity in the rat was ≥ 100 mg/kg bw/day. As explained in the analogue justification the target and the source substances are considered to be similar in their toxicological behvior. Therefore, it is considered that the target and the source substance is unlikely to lead to differences in developemtnal toxicity.
Reference
Effect on developmental toxicity: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 56 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The available information comprises an adequate, reliable (Klimisch score 1) and consistent study, from a reference substance with similar structure and intrinsic properties. Read-across is justified based on similarities in PC/ECO/TOX properties (refer to endpoint discussion for further details).
The selected studies are thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.7, in accordance with Annex XI, 1.5, of Regulation (EC) No 1907/2006.
Effect on developmental toxicity: via inhalation route
- Endpoint conclusion:
- no study available
Effect on developmental toxicity: via dermal route
- Endpoint conclusion:
- no study available
Additional information
Developmental toxicity of barium chloride dihydrate was evaluated in a recent prenatal developmental toxicity study according to OECD 414 by daily administration of the test item at dose levels of 0, 10, 30 or 100 mg barium chloride dihydrate/kg bw/day to pregnant rats from gestation day 1 up to and including gestation day 20 (TNO, 2014). No effects on body weights, food consumption and clinical signs were observed. Maternal toxicity was evidenced by the spontaneous deaths of two animals on gestation day 21 only and the conditional decline of another animal on gestation day 21 in the high dose group (100 mg/kg bw/day).
No developmental toxicity or treatment-related observations, whatsoever in external, visceral and skeletal foetal examinations were observed in any dose level.
The NOAEL for maternal toxicity was therefore 30 mg barium chloride dihydrate/kg bw/day (equivalent to 17 mg barium/kg bw/day). In absence of developmental effects, the NOAEL for prenatal developmental toxicity in the rat was ≥ 100 mg barium chloride dihydrate/kg bw/day (equivalent to ≥ 56 mg barium/kg bw/day).
Justification for classification or non-classification
The available data on reproductive toxicity do not meet the criteria for classification according to Regulation (EC) 1272/2008, and are therefore conclusive but not sufficient for classification.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.